Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
05/2002
05/22/2002CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones
05/16/2002WO2001087308B1 Treatment of fibromyalgia and chronic fatigue syndrome
05/16/2002US20020058813 Spiro-indolines as Y5 receptor antagonists
05/16/2002DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors
05/15/2002EP1204665A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204663A1 Novel spiro compounds
05/15/2002EP1204662A1 Azaindoles having serotonin receptor affinity
05/15/2002EP1204640A2 Chemokine receptor antagonists and methods of use therefor
05/14/2002US6388077 Spiro compounds
05/14/2002US6387916 Administering to humans, animals
05/10/2002WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/10/2002WO2002012237A3 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
05/10/2002WO2001032664A3 Novel thiophenes and method for polymerization of said thiophenes
05/10/2002WO2001023386A3 Benzodiazepin derivatives, the production and use thereof
05/10/2002CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/09/2002US20020055528 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
05/08/2002EP0888301A4 Mcbi analogs of cc-1065 and the duocarmycins
05/08/2002EP0723545B1 Quinolizinone type compounds
05/08/2002CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound
05/07/2002US6384045 Tricyclic and tetracyclic pyrones
05/02/2002US20020052500 Reacting perylene-3,4,9,10-tetracarboximide or derivatives with formaldehyde to form bis(hydroxymethyl)perylene-3,4,9,10-tetracarboximide, which further reacts with a precursor of organic redicals
05/02/2002US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides
05/02/2002EP1200433A1 C-6 RING-SUBSTITUTED PYRIDO 1,2- i a /i ]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
04/2002
04/30/2002US6381169 High density non-volatile memory device
04/30/2002US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells
04/25/2002WO2002032907A1 Extraction method
04/25/2002US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials
04/23/2002US6376488 Benzoxazine α-1 adrenergic compounds
04/18/2002WO2002030942A2 Anhydro sugar derivatives of indolocarbazoles
04/18/2002WO2002030936A1 Pyrrole-condensed morphinoid derivatives
04/18/2002WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
04/18/2002WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses
04/18/2002WO2002030426A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
04/18/2002WO2001064681A3 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
04/18/2002US20020044885 Device and method for photoactivation
04/18/2002CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
04/18/2002CA2425121A1 Ether compounds and compositions for cholesterol management and related uses
04/18/2002CA2424438A1 Anhydro sugar derivatives of indolocarbazoles
04/17/2002EP1197485A1 Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
04/17/2002EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
04/17/2002EP1196199A2 Water soluble multi-biotin-containing compounds
04/17/2002CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
04/17/2002CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect
04/11/2002WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
04/11/2002US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
04/11/2002DE10047529A1 New triazolyl-thiazolyl-epothilone derivatives, useful as fungicides or in the treatment of tumors and cell growth disorders, e.g. cancers
04/10/2002CN1344257A Fused pydiopyridazine inhibitors of cGMP phosphodiesterase
04/10/2002CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors
04/04/2002WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents
04/04/2002US20020040019 Substituted pyrazoles
04/04/2002CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents
04/03/2002EP1193270A2 Pyrrolobenzodiazepines
04/03/2002EP1192165A2 Substituted heterocycle fused gamma-carbolines
04/03/2002EP1192164A1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
04/02/2002US6365735 Alkaloids formed by reduction or cyanation
03/2002
03/28/2002WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
03/28/2002WO2002024692A1 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
03/28/2002US20020038028 For therapy of neurological and psychological disorders are claimed.
03/28/2002CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
03/27/2002EP1191020A2 Material for organic electroluminescence device and use thereof
03/27/2002EP1189905A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189904A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189889A1 Compositions and methods for inhibiting cell death
03/27/2002EP0946176B1 The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for manufacture of a medicament for the treatment of helicobacter pylori infections and associated gastroduodenal diseases
03/27/2002CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases
03/27/2002CN1081641C Carbapenem derivatives and antimicrobials
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362331 Pyrrolo(2,1-c)(1,4)benzodiazepine
03/26/2002US6362178 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
03/21/2002WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors
03/21/2002WO2002006361A3 Novel photochromic polymers and methods of synthesizing same
03/21/2002US20020035262 7-hetero-bicyclo[2.2.1]-heptanes
03/21/2002US20020035258 Quinolone carboxylic acid derivatives
03/21/2002US20020035114 Substituted dimeric compounds
03/21/2002US20020034754 Fluorescent quenching detection reagents and methods
03/20/2002EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
03/20/2002EP1187616A1 Thrombin inhibitors
03/20/2002EP1187613A1 Amide substituted imidazoquinolines
03/20/2002EP1187592A2 Alpha v integrin receptor antagonists
03/19/2002US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system
03/19/2002US6358946 C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders
03/14/2002WO2002020533A2 Benzoxazine alpha-1 adrenergic compounds
03/14/2002WO2002020530A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
03/14/2002WO2002020013A2 A method for treating allergies using substituted pyrazoles
03/14/2002WO2002020011A2 A method for treating allergies using substituted pyrazoles
03/14/2002US20020032200 2-Substituted imidazo[1,2-A]pyridine derivatives
03/14/2002DE10042655A1 Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion Process for the preparation of inhibitors of cell adhesion
03/14/2002CA2421510A1 A method for treating allergies using substituted pyrazoles
03/14/2002CA2421493A1 A method for treating allergies using substituted pyrazoles
03/14/2002CA2417594A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355798 Ligands for gamma-aminobutyric acid receptors; anticonvulsants, anxiolytic agents
03/12/2002US6355653 Amino-triazolopyridine derivatives
03/12/2002US6355638 Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
03/07/2002WO2002018384A1 Process for the preparation of vitronectin receptor antagonists
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 111